1. Somyajit, Kumar, Subramanya, Shreelakshmi, Nagaraju, Ganesh. 2010. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. In Carcinogenesis, 31, 2031-8. doi:10.1093/carcin/bgq210. https://pubmed.ncbi.nlm.nih.gov/20952512/
2. Greenhough, Luke A, Liang, Chih-Chao, Belan, Ondrej, Boulton, Simon J, West, Stephen C. 2023. Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor. In Nature, 619, 650-657. doi:10.1038/s41586-023-06179-1. https://pubmed.ncbi.nlm.nih.gov/37344587/
3. Kalvala, Arjun, Gao, Li, Aguila, Brittany, Villalona-Calero, Miguel A, Duan, Wenrui. 2016. Rad51C-ATXN7 fusion gene expression in colorectal tumors. In Molecular cancer, 15, 47. doi:10.1186/s12943-016-0527-1. https://pubmed.ncbi.nlm.nih.gov/27296891/
4. Olvera-León, Rebeca, Zhang, Fang, Offord, Victoria, Waters, Andrew J, Adams, David J. 2024. High-resolution functional mapping of RAD51C by saturation genome editing. In Cell, 187, 5719-5734.e19. doi:10.1016/j.cell.2024.08.039. https://pubmed.ncbi.nlm.nih.gov/39299233/
5. Lilyquist, Jenna, LaDuca, Holly, Polley, Eric, Couch, Fergus J, Goldgar, David E. 2017. Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. In Gynecologic oncology, 147, 375-380. doi:10.1016/j.ygyno.2017.08.030. https://pubmed.ncbi.nlm.nih.gov/28888541/